The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
D1
Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1
Immunology and Microbiology (miscellaneous)
D1
Medicine (miscellaneous)
D1
Neuroscience (miscellaneous)
3.
Konkoly, J.,
Kunka, Á.,
Szentágotai, A.,
Lisztes, E.,
Marincsák, R.,
Racskó, M.,
Bohács, J.,
Pintér, E.,
Gaszner, B.,
Tóth, I. B.,
Kormos, V.:
Identification of Optimal Decalcification Method and Tissue Preparation Protocol for RNAscope in Situ Hybridization in Rodent Incisor Tooth.
Dentistry Journal. 13 (11), 1-15, (article identifier: 538), 2025.
Ádám, D.,
Arany, J.,
Tóth, K. F.,
Pető, O.,
Nyitrai, T.,
Tóth, I. B.,
Póliska, S.,
Zouboulis, C. C.,
Oláh, A.:
The TRPM5 antagonist triphenylphosphine oxide (TPPO) increases sebaceous lipogenesis and modulates immune phenotype of human sebocytes in a TRPM5-independent manner.
Exp. Dermatol. 34 (5), 1-13, (article identifier: 70115), 2025.
Horváth, Á.,
Steib, A.,
Nehr-Majoros, A.,
Kántás, B.,
Király, Á.,
Racskó, M.,
Tóth, I. B.,
Szánti-Pintér, E.,
Kudová, E.,
Skoda-Földes, R.,
Helyes, Z.,
Szőke, É.:
Anti-Nociceptive Effects of Sphingomyelinase and Methyl-Beta-Cyclodextrin in the Icilin-Induced Mouse Pain Model.
Int. J. Mol. Sci. 25 (9), 4637, 2024.
Ádám, D.,
Arany, J.,
Tóth, K. F.,
Pető, O.,
Nyitrai, T.,
Tóth, I. B.,
Póliska, S.,
Zouboulis, C. C.,
Oláh, A.:
The TRPM5 antagonist triphenylphosphine oxide increases sebaceous lipogenesis and modulates immune phenotype of human sebocytes in a TRPM5-independent manner.
J. Invest. Dermatol. 144 (12_Suppl), S313, 2024.
Ádám, D.,
Arany, J.,
Pető, O.,
Tóth, I. B.,
Zouboulis, C. C.,
Oláh, A.:
The TRPM5 antagonist TPPO increases sebaceous lipogenesis and exerts pro-inflammatory effects via activation of Akt and p38 MAPK cascades.
J. Invest. Dermatol. 143 (11), S354, 2023.
